Literature DB >> 12834348

The extended interactions and Gla domain of blood coagulation factor Xa.

Stephanie X Wang1, Eugene Hur, Carolyn A Sousa, Linda Brinen, Eric J Slivka, Robert J Fletterick.   

Abstract

The serine protease factor Xa (FXa) is inhibited by ecotin with picomolar affinity. The structure of the tetrameric complex of ecotin variant M84R (M84R) with FXa has been determined to 2.8 A. Substrate directed induced fit of the binding interactions at the S2 and S4 pockets modulates the discrimination of the protease. Specifically, the Tyr at position 99 of FXa changes its conformation with respect to incoming ligand, changing the size of the S2 and S4 pockets. The role of residue 192 in substrate and inhibitor recognition is also examined. Gln 192 from FXa forms a hydrogen bond with the P2 carbonyl group of ecotin. This confirms previous biochemical and structural analyses on thrombin and activated protein C, which suggested that residue 192 may play a more general role in mediating the interactions between coagulation proteases and their inhibitors. The structure of ecotin M84R-FXa (M84R-FXa) also reveals the structure of the Gla domain in the presence of Mg(2+). The first 11 residues of the domain assume a novel conformation and likely represent an intermediate folding state of the domain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834348     DOI: 10.1021/bi027320a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Lipid specificity of the membrane binding domain of coagulation factor X.

Authors:  M P Muller; Y Wang; J H Morrissey; E Tajkhorshid
Journal:  J Thromb Haemost       Date:  2017-09-01       Impact factor: 5.824

2.  Understanding selectivity of hard and soft metal cations within biological systems using the subvalence concept. I. Application to blood coagulation: direct cation-protein electronic effects vs. indirect interactions through water networks.

Authors:  B de Courcy; L G Pedersen; O Parisel; N Gresh; B Silvi; J Pilmé; J-P Piquemal
Journal:  J Chem Theory Comput       Date:  2010-03-12       Impact factor: 6.006

3.  Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated Protein C: role of magnesium at physiological calcium.

Authors:  Kanagasabai Vadivel; Sayeh Agah; Amanda S Messer; Duilio Cascio; Madhu S Bajaj; Sriram Krishnaswamy; Charles T Esmon; Kaillathe Padmanabhan; S Paul Bajaj
Journal:  J Mol Biol       Date:  2013-02-20       Impact factor: 5.469

4.  A Kirkwood-Buff derived force field for alkaline earth halide salts.

Authors:  Nawavi Naleem; Nikolaos Bentenitis; Paul E Smith
Journal:  J Chem Phys       Date:  2018-06-14       Impact factor: 3.488

5.  Molecular dynamics simulations of Factor Xa: insight into conformational transition of its binding subsites.

Authors:  Narender Singh; James M Briggs
Journal:  Biopolymers       Date:  2008-12       Impact factor: 2.505

6.  Contribution of magnesium in binding of factor IXa to the phospholipid surface: implications for vitamin K-dependent coagulation proteins.

Authors:  A S Messer; W H Velander; S P Bajaj
Journal:  J Thromb Haemost       Date:  2009-10-08       Impact factor: 5.824

7.  Role of magnesium in factor XIa catalyzed activation of factor IX: calcium binding to factor IX under physiologic magnesium.

Authors:  S Agah; S P Bajaj
Journal:  J Thromb Haemost       Date:  2009-06-03       Impact factor: 5.824

8.  The serine protease domain of MASP-3: enzymatic properties and crystal structure in complex with ecotin.

Authors:  Christine Gaboriaud; Rajesh Kumar Gupta; Lydie Martin; Monique Lacroix; Laurence Serre; Florence Teillet; Gérard J Arlaud; Véronique Rossi; Nicole M Thielens
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

9.  Analysis of 180 Genetic Variants in a New Interactive FX Variant Database Reveals Novel Insights into FX Deficiency.

Authors:  Victoria A Harris; Weining Lin; Stephen J Perkins
Journal:  TH Open       Date:  2021-11-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.